Salesforce and WPP-backed Domo, which emerged from stealth in 2015 with a $2bn valuation, has filed to go public in an attempt to secure capital and avoid having to reduce its business.

Neuronetics has filed for an $86.3m initial public offering on Nasdaq that will offer exits to corporates Pfizer, General Electric and Ascension.

The company will sell up to approximately 7.7 million shares priced at $22.8 to $28.7, valuing the Rocket Internet-backed business at $618m to $758m.

The EMS-backed gene therapy developer has filed for an $86.3m offering having raised about the same amount in venture funding.

BridgeBio Pharma retains a majority stake in spinoff Eidos, which has raised $91m in funding in just over a year.

Scholar Rock, a spinal muscular atrophy therapy developer backed by Kraft Group, floated in the middle of its range.

The electric bus producer, which is backed by BMW, GM, Mitsui, Edison Energy and Exelon, is raising money at a valuation of up to $840m.

Baidu, Legend Holdings and Tencent are all in line to exit the used vehicle marketplace, which plans to go public in the US.

The Nan Fung-backed neurological disorder treatment developer has raised $135m in funding in the past two years.